The treatment of Basal Joint Arthritis & Hypoglycemia with vitamins

Basal Joint Arthritis and Hypoglycemia: Mitamins custom make quality formulas for the treatment of Basal Joint Arthritis & Hypoglycemia with vitamins. A Basal Joint Arthritis & Hypoglycemia formula will be made to suit you, using quality brand name ingredients. Mitamins produce custom made vitamin and supplement formulas to suit your individual health needs conveniently in one formula, one bottle and one dosage. For assistance, call toll free: 1-866-585-1390
Your Supplements Facts - Covers the formulas above
Supplement Facts

Specially Formulated for: Basal Joint Arthritis and Hypoglycemia

  • Amount Per Serving
    % DV
    Vitamin C
    100
    mg
    167%
    Niacin
    50
    mg
    250%
    Chromium
    100
    mcg
    83%
    Potassium
    100
    mg
    3%
    Omega - 3 Fatty Acids
    100
    mg
    *
    Chondroitin Sulfate
    200
    mg
    *
    MSM
    100
    mg
    *
  • Amount Per Serving
    % DV
    Bioflavonoid Concentrate
    100
    mg
    *
    Feverfew Extract
    50
    mg
    *
    American Ginseng Extract
    100
    mg
    *
    Licorice Extract
    250
    mg
    *
    Ginger Extract
    100
    mg
    *
    White Willow Extract
    60
    mg
    *
    * Daily Value (DV) not established
Name Your Supplement Bottle - Just how you like it
The current default name is: 
 
(Click in box to change)
Your Perfect Supplement - Custom-made just for you
Formulas form 35 Years of Medical Practice
Basal Joint Arthritis and Hypoglycemia
Serving Size:4-5

Basal Joint Arthritis and Hypoglycemia Formulas Details

Customize Your Supplements - Check all that apply
4A Select additional condition(s) you want to address:


4B Select all the medication(s) you are taking:
If your concern or medication is not listed here, use our Formulator, which covers 680 concerns and 1600 drugs, Click here!
Latest Health Related News:
Cerimon Pharmaceuticals Initiates Phase I Clinical Study Of Topical Diclofenac Sodium Patch
Cerimon Pharmaceuticals, Inc., announced it has initiated a Phase I clinical study of a novel diclofenac sodium patch, the Company's lead pain asset. The study will evaluate safety, tolerability, and systemic pharmacokinetics of a topical patch formulation of diclofenac sodium, a non-steroidal anti-inflammatory drug (NSAID), in 16 healthy volunteers. The Phase I study is expected to be completed in the fourth quarter of 2007.
Should General Practitioners Take Back 24 Hour Responsibility For Patients?
As the number of complaints regarding out of hours services are rising in the United Kingdom, two experts debate whether General Practitioners (GPs) should resume 24 hour responsibility for their patients. You can read the Head-to-Head article in the British Medical Journal (BMJ), this week's issue.
This information concerning the support of Basal Joint Arthritis and Hypoglycemia treatments provide basic knowledge which should always be discussed with your own health practitioner.
Any Questions, Call Us Toll Free: 1-866-585-1390
Live Chat System

manufactured In USA

  verisign          Trust E Finalmark

Custom Vitamins and Nutritional Supplements for Supporting Age-Related Cognitive Decline and Aging Treatments